Rivaroxaban, sold under the brand name Xarelto, among others, is an anticoagulant medication (blood thinner), which is taken by mouth.
Learn about Xarelto, dosing, proper use and what to know before beginning treatment.There are no dose modifications required for age, weight, or gender.Find patient medical information for Xarelto Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders.Rivaroxaban is an oral medication used to treat and prevent blood clots in the legs and lungs.Instruct patients to immediately report if they experience any of the above signs or symptoms.
Compare Xarelto 20 mg prices from verified online pharmacies or local U.S pharmacies.A history of traumatic or repeated epidural or spinal punctures.Do not take Xarelto and tell your doctor if any of these apply to you.Check out Side Effects Of Xarelto and let us help you understand what is going on.Learn about the role Xarelto may play in erectile dysfunction.Do not stop taking rivaroxaban without talking to your doctor.
Take special care with Xarelto - if you have moderate or severe kidney disease.Please seek medical advice before starting, changing or terminating any medical treatment.A server error occured, please refresh the page and try again.
Consumer information about rivaroxaban (Xarelto), a drug prescribed to prevent or treat AFib, DVT, and pulmonary embolism.
Do not stop taking XARELTO without talking to the doctor who prescribes it for you.Complete analysis from patient reviews and trusted online health resources, including first-hand experiences.Erectile dysfunction can be caused by many factors, including medication.Find a comprehensive guide to possible side effects including common and rare side effects when taking Xarelto (Rivaroxaban Film-Coated Oral Tablets) for healthcare.Xarelto (Rivaroxaban) is a new alternative for prevention of stroke for patients with atrial fibrillation.
Rivaroxaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin.